These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1431 related articles for article (PubMed ID: 33907095)

  • 61. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
    Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
    Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiac transthyretin amyloidosis.
    Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
    Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
    Hood CJ; Hendren NS; Pedretti R; Roth LR; Saelices L; Grodin JL
    Curr Heart Fail Rep; 2022 Oct; 19(5):356-363. PubMed ID: 35930129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
    Akatsuka T; Fujimoto N; Ishiyama M; Nakamori S; Imanaka-Yoshida K; Dohi K
    ESC Heart Fail; 2021 Aug; 8(4):3422-3426. PubMed ID: 34145794
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
    Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
    ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted treatments of AL and ATTR amyloidosis.
    Chandrashekar P; Desai AK; Trachtenberg BH
    Heart Fail Rev; 2022 Sep; 27(5):1587-1603. PubMed ID: 34783948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strong positive light chain immunostaining in a patient with transthyretin amyloidosis.
    Chen J; Chen H; Zhou L; Liu D; Du F; Xiang H
    Hematology; 2023 Dec; 28(1):2244315. PubMed ID: 37551718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
    Lohrmann G; Pipilas A; Mussinelli R; Gopal DM; Berk JL; Connors LH; Vellanki N; Hellawell J; Siddiqi OK; Fox J; Maurer MS; Ruberg FL
    J Card Fail; 2020 Sep; 26(9):753-759. PubMed ID: 31805416
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
    Okamoto N; Kubo T; Nakashima Y; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Intern Med; 2020 Feb; 59(3):339-343. PubMed ID: 31588087
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis.
    Quarta CC; Gonzalez-Lopez E; Gilbertson JA; Botcher N; Rowczenio D; Petrie A; Rezk T; Youngstein T; Mahmood S; Sachchithanantham S; Lachmann HJ; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Gillmore JD
    Eur Heart J; 2017 Jun; 38(24):1905-1908. PubMed ID: 28605421
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant.
    Yagi S; Yamazaki H; Kusunose K; Osaki Y; Ise T; Kadota M; Tserensonom M; Kawabata Y; Hara T; Ueno R; Saijo Y; Matsuura T; Yamaguchi K; Yamada H; Fukuda D; Soeki T; Wakatsuki T; Sata M
    J Med Invest; 2022; 69(3.4):320-322. PubMed ID: 36244789
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
    López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
    Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy.
    He S; Tian Z; Guan H; Li J; Fang Q; Zhang S
    Orphanet J Rare Dis; 2019 Nov; 14(1):251. PubMed ID: 31718691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly.
    Sekijima Y; Uchiyama S; Tojo K; Sano K; Shimizu Y; Imaeda T; Hoshii Y; Kato H; Ikeda S
    Hum Pathol; 2011 Nov; 42(11):1785-91. PubMed ID: 21733562
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
    Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
    Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
    Lane T; Fontana M; Martinez-Naharro A; Quarta CC; Whelan CJ; Petrie A; Rowczenio DM; Gilbertson JA; Hutt DF; Rezk T; Strehina SG; Caringal-Galima J; Manwani R; Sharpley FA; Wechalekar AD; Lachmann HJ; Mahmood S; Sachchithanantham S; Drage EPS; Jenner HD; McDonald R; Bertolli O; Calleja A; Hawkins PN; Gillmore JD
    Circulation; 2019 Jul; 140(1):16-26. PubMed ID: 31109193
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
    Judge DP; Kristen AV; Grogan M; Maurer MS; Falk RH; Hanna M; Gillmore J; Garg P; Vaishnaw AK; Harrop J; Powell C; Karsten V; Zhang X; Sweetser MT; Vest J; Hawkins PN
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):357-370. PubMed ID: 32062791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].
    Yu TP; Hou J; Yang TJ; Lei S; Yang M; Su YY; Chen YC; Wu Y; Chen XQ
    Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):671-677. PubMed ID: 37408396
    [No Abstract]   [Full Text] [Related]  

  • 80. Transthyretin-related amyloid in a saphenous vein. Histological diagnosis in a patient undergoing coronary artery bypass surgery.
    Farci F; De Martino A; Pratali S; Bortolotti U; Pucci A
    Cardiovasc Pathol; 2019; 41():21-23. PubMed ID: 31005793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.